[email protected]
CAS 18265-46-8 D-RIBOSE-5-PHOSPHATE DISODIUM SALT molecular structure lightbox
CAS RN: 18265-46-8

D-RIBOSE-5-PHOSPHATE DISODIUM SALT

Product Availability

Choose a grade to view its available package options.

1 package records0 with current stock1 grade group
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20260323 1ml Out of stock 8-10 business days Inquiry
  • Product code: SSC-084569
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 1g
  • Available purity: ＞95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 18265-46-8
Pack Size Recorded Purity Available Qty Ship From Inquiry
1g ＞95% 0 Out of Stock Beijing Inquiry

18265-46-8 / disodium;(2R,3S,4R)-4-hydroxy-1-oxo-5-phosphonooxypentane-2,3-diolate

Standard CAS: 18265-46-8 Multi CAS: No
Basic Information Computed Properties Safety & Transport

Basic Information

CAS
18265-46-8
Multi CAS
No
Molecular Formula
C5H9Na2O8P
Molecular Weight
274.070000
Exact Mass
273.983043
SMILES
C([C@H]([C@H]([C@H](C=O)[O-])[O-])O)OP(=O)(O)O.[Na+].[Na+]
InChI
InChI=1S/C5H9O8P.2Na/c6-1-3(7)5(9)4(8)2-13-14(10,11)12;;/h1,3-5,8H,2H2,(H2,10,11,12);;/q-2;2*+1/t3-,4+,5-;;/m0../s1
InChIKey
WLPAKKFQVSXILQ-LMQMBFIUSA-N

Computed Properties

Structural Parameters

Heavy atom count
16
Fraction Csp3
0.8
Rotatable bonds
6
H-bond acceptors
6
H-bond donors
3
Molar refractivity
37.64
TPSA
150.18

LogP / Solubility

WLOGP
-9.88
MLOGP
-8.68
XLogP3
-9.88
Consensus LogP
-9.48
Log S (ESOL)
5.08
Class (ESOL)
Highly soluble
Log S (Ali)
5.33
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
6.04
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-11.41

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
3

Safety & Transport

GHS Hazard Statements
Not Classified Reported as not meeting GHS hazard criteria by 4 of 4 companies. For more detailed information, please visit ECHA C&L website.

Customers Also Viewed

Get In Touch

Contact Us